氧化三甲胺与房颤患者心血管死亡及脑血管病变相关
在瑞士房颤队列2379例患者中,基线血浆TMAO最高三分位者较最低三分位者心血管死亡风险升高(HR 1.86,95%CI 1.21–2.88,p<0.01),全因死亡风险亦升高(HR 1.65,95%CI 1.17–2.32,p<0.01)。1722例基线脑MRI显示最高三分位者梗死体积更大且小非皮质梗死几率更高。
要点
- 房颤患者高TMAO水平与心血管死亡风险升高独立相关
- 高TMAO三分位者脑MRI梗死体积更大、小非皮质梗死更常见
- 高TMAO三分位者更高龄、肾功能更差、糖尿病和心衰患病率更高
核心结论
- 房颤患者中高TMAO水平与心血管死亡风险升高及脑梗死发生相关。
研究设计与样本
- 前瞻性队列研究,纳入瑞士房颤队列2379例患者,基线测量血浆TMAO,1722例完成基线脑MRI,随访4年(Q1-Q3:3.0-5.0年),按TMAO三分位分层,采用Cox比例风险模型及线性/逻辑混合效应模型校正危险因素。
主要发现
- 最高三分位者较最低三分位者更年老(75.4±8.1 vs 70.6±8.5岁,p<0.01)。
- 最高三分位者肾小球滤过率中位数更低(49.0 mL/min/1.73 m2(35.6-62.5)vs 67.3 mL/min/1.73 m2(57.8-78.9),p<0.01)。
- 最高三分位者糖尿病患病率26.9% vs 9.1%(p<0.01),心衰患病率37.9% vs 15.8%(p<0.01)。
- 最高三分位者全因死亡HR 1.65(95%CI 1.17–2.32,p<0.01),心血管死亡HR 1.86(95%CI 1.21–2.88,p<0.01)。
- 最高三分位者脑MRI梗死体积更大(对数转换体积的指数化估计值1.89,95%CI 1.11–3.21,p=0.02),小非皮质梗死OR 1.61(95%CI 1.16–2.22,p<0.01)。
临床怎么用
- 在房颤患者中可关注TMAO水平用于心血管死亡和脑梗死风险分层。
- 高TMAO患者常合并高龄、肾功能不全、糖尿病和心衰,需综合管理这些危险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Trimethylamine-N-oxide (TMAO) is a metabolite derived from the microbial processing of dietary phosphatidylcholine and carnitine and the subsequent hepatic oxidation. Due to its prothrombotic and inflammatory mechanisms, we aimed to assess its role in the prediction of adverse events in a susceptible population, namely patients with atrial fibrillation. METHODS: Baseline TMAO plasma levels were measured by liquid chromatography-tandem mass spectrometry in 2379 subjects from the ongoing Swiss Atrial Fibrillation cohort. 1722 underwent brain MRI at baseline. Participants were prospectively followed for 4 years (Q1-Q3: 3.0-5.0) and stratified into baseline TMAO tertiles. Cox proportional hazards and linear and logistic mixed effect models were employed adjusting for risk factors. RESULTS: Subjects in the highest TMAO tertile were older (75.4±8.1 vs 70.6±8.5 years, p<0.01), had poorer renal function (median glomerular filtration rate: 49.0 mL/min/1.73 m2 (35.6-62.5) vs 67.3 mL/min/1.73 m2 (57.8-78.9), p<0.01), were more likely to have diabetes (26.9% vs 9.1%, p<0.01) and had a higher prevalence of heart failure (37.9% vs 15.8%, p<0.01) compared with patients in the lowest tertile. Oral anticoagulants were taken by 89.1%, 94.0% and 88.2% of participants, respectively (from high to low tertiles). Cox models, adjusting for baseline covariates, showed increased total mortality (HR 1.65, 95% CI 1.17 to 2.32, p<0.01) as well as cardiovascular mortality (HR 1.86, 95% CI 1.21 to 2.88, p<0.01) in the highest compared with the lowest tertile. When present, subjects in the highest tertile had more voluminous, large, non-cortical and cortical infarcts on MRI (log-transformed volumes; exponentiated estimate 1.89, 95% CI 1.11 to 3.21, p=0.02) and a higher chance of small non-cortical infarcts (OR 1.61, 95% CI 1.16 to 2.22, p<0.01). CONCLUSIONS: High levels of TMAO are associated with increased risk of cardiovascular mortality and cerebral infarction in patients with atrial fibrillation. TRIAL REGISTRATION NUMBER: NCT02105844.
引用
- Luciani, Müller, Vanetta, et al. Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation. Heart. 2023. PMID: 36593094. doi:10.1136/heartjnl-2022-321300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。